Skip to main content
FinSpry Logo
FinSpry
TARS logo
TARS
(NASDAQ)
Tarsus Pharmaceuticals, Inc.
$87.22-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Tarsus Pharmaceuticals (TARS) Stock Price & Financial Analysis

Tarsus Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$87.01 - $90.75
52-Week High$91.53
52-Week Low$48.20
Open$89.67
Volume1.81M
Average Volume (3M)805.60K
Market Cap3.90B
Shares Outstanding42.96M
Price to Sales (P/S)7.29
Price to Book (P/B)11.18
EV/EBITDA-101.70
Revenue (TTM)535.08M
Net Income (TTM)-48.27M
Free Cash Flow (TTM)-31.54M
EPS (TTM)$-1.13
Profit Margin-9.02%
Operating Margin-9.50%
Return on Equity (ROE)-13.83%
Debt to Equity0.25
50-Day MA$66.45
200-Day MA$68.79
52-Week Change53.31%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Tarsus Pharmaceuticals

What is the current stock price for TARS?

As of the latest trading session, TARS stock trades at $87.22. The 52-week range is $48.20–$91.53, with a day range of $87.01–$90.75.

What is the P/E ratio for TARS?

The P/E ratio (Price-to-Earnings) for TARS is shown in the Key Statistics section. This valuation metric helps compare Tarsus Pharmaceuticals, Inc. to industry peers.

Does TARS pay dividends?

Tarsus Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TARS?

Based on 7 analysts, the consensus for TARS is Buy.

What is the market cap of TARS?

Tarsus Pharmaceuticals's market capitalization is $3.75B, classifying it as a mid-cap company. Tarsus Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.